Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹0.75Admitted-Finance | ₹0.75 | L1 | Admitted-Finance |
| 2 | L2₹0.89+₹0.14 (18.7%)Admitted-Finance | ₹0.89+₹0.14 (18.7%) | L2 | Admitted-Finance |
| 3 | L3₹0.91+₹0.16 (21.3%)Admitted-Finance | ₹0.91+₹0.16 (21.3%) | L3 | Admitted-Finance |
| 4 | L4₹1.34+₹0.59 (78.7%)Admitted-Finance | ₹1.34+₹0.59 (78.7%) | L4 | Admitted-Finance |
| 5 | L5₹3,672.90+₹3,672.15 (489620.0%)Admitted-Finance SHOP NO 7 C2C MARKET NO 1 POCKET 2 JANAKPURI DELHI | NEW DELHI | DELHI | 110001 | ₹3,672.90+₹3,672.15 (489620.0%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | NEW LIFE MEDICOS L6 | Gagan Associates L10 | UJJAWAL OVERSEAS (I) PVT LTD L3 | GOYAL PHARMACEUTICALS L5 | SMPL Life Sciences Pvt. Ltd. L8 | Sajiva Medsales Private Limited L2 | SHIVAAY PHARMACY L1 | DPNR Medicals L4 | Mahaluxmi Surgical AND Medicine Distributors L9 | MASTODON BIOTECH L7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Endo | |||||||||||||
| 1.01 | DENOSUMAB 60MG INJ | 86 | No | 4,028 ₹4,229.4 | - | - | 3,498 ₹3,672.9 | 3,365 ₹3,533.25 Lowest | - | - | - | - | - |
| 2.01 | Octreotide LAR 20mg Inj | 41 | VIAL | - | - | - | - | 7,920 ₹8,316 Lowest | - | - | - | 12,300 ₹12,915 | 9,600 ₹10,080 |
| 3.01 | Inj Romosozumab 210mg/2.34ml (pack of 2 PFS) | 23 | PFS | - | 22,405 ₹23,525.25 Lowest | - | - | - | - | - | - | - | - |
| 4.01 | Dapagliflozin 5 Mg Tab | 18,000 | No | - | - | 0.87 ₹0.91 | - | 0.7 ₹0.73 | 0.85 ₹0.89 | 0.71 ₹0.75 | 0.44 ₹0.46 Lowest | - | - |
| 5.01 | Glipizide 5mg Tab | 2,600 | No | - | - | - | - | - | - | - | 0.84 ₹0.88 Lowest | - | - |
Tender Value
₹12.0 L
EMD Value
₹59,922
Closing Date
20 May 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 824, 646/Endo(Drugs)/IFA RE-22/2026-27 FOR AHRR
2026_ARMY_762797_1
2433/MS/EXP/D 824, 646/Endo(Drugs)/IFA RE-22/2026-27
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹59,922
Yes
4 Jul 2026
30 Apr 2026
21 May 2026
30 Apr 2026
20 May 2026
30 Apr 2026
30 Apr 2026 - 20 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Endo | |||||
| 1.01 | DENOSUMAB 60MG INJ | 86 | No | - | - |
| 2.01 | Octreotide LAR 20mg Inj | 41 | VIAL | - | - |
| 3.01 | Inj Romosozumab 210mg/2.34ml (pack of 2 PFS) | 23 | PFS | - | - |
| 4.01 | Dapagliflozin 5 Mg Tab | 18,000 | No | - | - |
| 5.01 | Glipizide 5mg Tab | 2,600 | No | - | - |
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.57 MB
RFP.pdf
Tender Documents • 1.31 MB
BOQ_854455.xls
BOQ • 0.86 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .